CSIMarket
 

Cryoport inc   (CYRX)
Other Ticker:  
 

Cryoport Inc 's Working Capital Per Sales

CYRX's Working Capital and Revenue growth



CYRX Working Capital Per Revenue (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Working Capital Change -13.62 % -11.71 % -6.83 % -9.9 % -13.31 %
Y / Y Revenue Change -5.13 % -7.12 % -11.12 % 20.1 % 6.94 %
Working Capital Per Revenue 2.26 2.31 2.34 2.31 2.48
Total Ranking # 1722 # 1943 # 2951 # 1652 # 1461
Seq. Working Capital Change -2.91 % -7.37 % -3.21 % -0.77 % -0.76 %
Seq. Revenue Change 1.96 % -1.52 % -9.23 % 4.07 % -0.18 %





Comment on CYRX's Working Capital Per Revenue in the fourth quarter 2023
Cryoport Inc 's Working Capital Per Revenue in the Q4 2023 sequentially fell to 2.26 but remained above Cryoport Inc 's average. Due to decrease of revenue year on year in the fourth quarter 2023 by -5.13%.

Within Healthcare sector 20 other companies have achieved lower Working Capital Per Revenue during the Q4 2023. While Cryoport Inc Working Capital Per Revenue overall ranking has impoved so far in the Q4 2023 to 1722, from total ranking in the third quarter 2023 at 1943.
Working Capital Per Revenue Ranking
Within: No.
Industry # 7
Sector # 21
S&P 500 # 1722


Working Capital Per Revenue Statistics
High Average Low
3.81
1.43
-0.59
(Sep 30 2020)   (March 31, 2014)



Financial Statements
Cryoport Inc 's Working Capital $ 491 Millions Visit CYRX's Balance sheet
Cryoport Inc 's Revenues $ 57 Millions Visit CYRX's Income Statement
Where are CYRX's Sales coming from? Visit CYRX's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2023, within Healthcare Sector Working Capital Per Revenue
Inspiremd Inc   5.95 
Curis Inc   5.87 
Mersana Therapeutics Inc   5.11 
Aadi Bioscience Inc   5.03 
Maxcyte inc   4.98 
Profound Medical Corp   4.94 
Soligenix inc   4.73 
Arcutis Biotherapeutics Inc   4.72 
Cara Therapeutics inc   4.69 
Zymeworks Inc   4.42 
Liquidia Corporation  4.41 
Meiragtx Holdings Plc  4.36 
Neurometrix Inc   4.13 
Editas Medicine Inc   3.94 
Macrogenics Inc   3.78 
Aclaris Therapeutics Inc   3.76 
Butterfly Network inc   3.55 
Pacific Biosciences Of California Inc   3.41 
Xencor Inc  3.22 
Travere Therapeutics Inc   3.21 
Zai Lab Limited  3.19 
Quanterix Corp  2.84 
Nurix Therapeutics Inc   2.78 
Igc Pharma Inc   2.71 
Cvrx inc  2.66 
Blueprint Medicines Corporation  2.58 
Ionis Pharmaceuticals Inc  2.57 
2seventy Bio Inc   2.41 
Adaptimmune Therapeutics Plc  2.32 
Morphosys Ag  2.31 
Date modified: 2024-03-13T23:04:03+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com